Nama Insights

Corgi Genomics & Precision Medicine ETF (GNMX)

Health · Corgi Funds · BATS

HealthETF
Corgi Genomics & Precision Medicine ETF (GNMX) is an exchange-traded fund in the Health category. It has $1.71M in assets and an expense ratio of 0.35%. The fund is an ETF that seeks to meet its objective by having Corgi Strategies, LLC actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the research, development, and commercialization of genomics and precision medicine technologies that enable improved disease detection, identifying and grouping patients based on genetic, molecular, or clinical char…
Assets under management$1.71M
Expense ratio0.35%
CategoryHealth
Dividend yield
NAV$29.96
Fund familyCorgi Funds
ExchangeBATS

Top holdings

The largest positions Corgi Genomics & Precision Medicine ETF reports, by weight.

HoldingNameWeight
TMO Thermo Fisher Scientific Inc 7.74%
VRTX Vertex Pharmaceuticals Inc 6.71%
ALNY Alnylam Pharmaceuticals Inc 3.88%
GH Guardant Health Inc 3.77%
MRNA Moderna Inc 3.74%
RVMD Revolution Medicines Inc Ordinary Shares 3.74%
ILMN Illumina Inc 3.73%
INCY Incyte Corp 3.06%
GMAB Genmab AS ADR 2.69%
TECH Bio-Techne Corp 2.50%

Other Health ETFs

Explore live GNMX data on Nama Insights →